Redeye Feed

2026-01-09 14:25:00 Lime (Q4 preview) - German momentum, slight forecast reductions, and the lowest valuation multiple since 2019

2026-01-08 08:08:00 Biovica (Q2 Review) - Setback on Timing, not on Long-Term Opportunity

2025-12-22 13:05:00 Vitrolife - Updating our view on the case

2025-12-19 11:59:00 Binero Group - Revisions following Acquisition and Capital Raise

2025-12-17 15:37:00 Truecaller - Ad revenue headwinds

2025-12-17 15:35:00 Waystream - Secures a significant SEK26m order

2025-12-17 15:34:00 AAC Clyde Space - INFLECION Financed

2025-12-11 11:40:00 Gapwaves - Funded to scale, setting sail

2025-12-08 21:30:00 Systemair (Q2 Review) - Solid performance

2025-12-05 08:59:00 Redeye Initiates Coverage of AAC Clyde Space

2025-12-05 08:58:00 Sprint Bioscience (Q3 review) - Gilead deal a strong confirmation

2025-12-01 13:20:00 MindArk (Q3 Review) - Gearing up for Q4

2025-11-28 11:44:00 Saniona (Q3 Review) - Gearing up for clinical development

2025-11-27 19:56:00 FluoGuide (Q3 review) - Busy news flow

2025-11-27 14:08:00 Lipum (Q3 review) - Going private

2025-11-27 14:07:00 Egetis (Q3 review) - Focus on US application

2025-11-27 14:06:00 AcouSort (Q3 review) - New collaboration alongside progress in existing one

2025-11-27 14:05:00 Xplora (Q3 Review) - Ringing in the harvest

2025-11-26 18:47:00 Hexatronic - Expanding US data centre services

2025-11-26 08:34:00 Redeye Initiates Coverage of Ferroamp

2025-11-21 16:03:00 Initiator Pharma (Q3 review) - Back in the clinic

2025-11-21 12:20:00 Flexion Mobile (Q3 Review) - Maintained growth outlook but weaker gross margins

2025-11-21 12:19:00 Lipigon (Q3 Review) - Topline Before Year-End

2025-11-20 15:19:00 Cinclus Pharma (Q3 review) - Pivotal studies underway

2025-11-20 15:18:00 Vertiseit - Entering audio as AI transforms the market

2025-11-20 15:17:00 Formpipe (Q3 Review) - Lasernet is taking form in better shape than assumed

2025-11-20 15:15:00 Cantargia (Q3 Review) - Planning for a Pivotal Study of Nadunolimab

2025-11-20 15:15:00 GiG Software (Q3 Review) - Solid results and positive outlook

2025-11-20 15:14:00 Enviro (Q3 Update) - Long-awaited clarity regarding plant CAPEX and profitability

2025-11-19 08:27:00 Gentoo Media (Q3 Review) - Profitability rebounds despite soft topline

2025-11-19 08:26:00 Nekkar (Q3 Review) - Solid Fundamentals; Recovery in 2026

2025-11-19 08:25:00 Corline Biomedical Q3 (Review) - Sales growth incoming

2025-11-19 08:23:00 Lytix Biopharma (Q3 Review) - Positive Clinical Readouts

2025-11-18 11:32:00 BioArctic (Q3 Review) - Stable progress

2025-11-18 11:31:00 Elicera Therapeutics (Q3 Review) - Entering a Catalyst-Dense Phase

2025-11-17 20:58:00 Thunderful (Q3 Review) - Promising pipeline in H1 2026

2025-11-17 09:33:00 Embracer (Q2-review) - Stronger H2 in sight

2025-11-17 09:32:00 CLS Q3 (Review) - Soft sales, but better quarters ahead

2025-11-17 09:31:00 Magle Group (Q3 review) - Recovered momentum, but some remaining uncertainties

2025-11-17 09:30:00 Navigo (Q3 review) - Nascent recovery

2025-11-17 09:29:00 Dala Energi (Q3 Update) - Out of the restructuring woods with focus on NAV growth

2025-11-17 09:28:00 Paxman Q3 (Review) - Softer sales than expected, but outlook remains strong

2025-11-17 09:27:00 Smart Eye (Q3 Review) - Buckled Into the Driver’s Seat

2025-11-14 12:35:00 AlzeCure Pharma (Q3 Review) - Clinical phase IIa study in focus

2025-11-14 12:34:00 BICO (Q3 Review) - A return to organic growth and adjusted EBITDA profitability

2025-11-14 12:33:00 Better Collective (Q3 Review) - On track for organic growth recovery

2025-11-14 12:32:00 Moberg Pharma (Q3 Review) - European footprint expanded, strengthening mid-/long-term outlook

2025-11-14 12:30:00 Surgical Science (Q3 review) - Soft margins and cash conversion

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Vem äger bolaget?

Redeye

Prenumeration

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden